News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Geron Corporation Clarifies License Rights For Cancer Vaccines
February 2, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MENLO PARK, Calif.--(BUSINESS WIRE)--Feb. 2, 2006--Geron Corporation (Nasdaq:GERN) today provided clarification with respect to license rights granted to third parties to develop cancer vaccines targeting telomerase.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Merck & Co.
MORE ON THIS TOPIC
Layoff Tracker
Eikon Cuts Workforce by 15%, Citing ‘External Forces’
May 22, 2025
·
210 min read
·
BioSpace Editorial Staff
Mergers & acquisitions
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target
May 22, 2025
·
4 min read
·
Annalee Armstrong
BROUGHT TO YOU BY PLIANCY
Webinar: Are We There Yet? Surviving and Thriving in the Never-ending Biotech Downturn
May 21, 2025
·
1 min read
·
BioSpace Insights
Collaboration
Genentech Bets Again on Orionis With Potential $2B+ in Crowded Molecular Glue Space
May 21, 2025
·
2 min read
·
Tristan Manalac
